News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–108
Matches
210
Sources here
21
Companies here
9
Search results Stored financial headlines

Active search

210 matching headlines

Ticker or company: ELMMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Helmerich & Payne (HP) Reports Q2: Everything You Need To Know Ahead Of Earnings

Helmerich & Payne (NYSE: HP) is set to announce its Q2 earnings this Wednesday after market close. The company missed revenue expectations last quarter, and analysts are projecting a 5.7% year-on-year revenue decline for the upcoming quarter. Despite past misses, investor sentiment in the …

HP main company
Sharemaestro market context Trend signal started 52 weeks +139.0% HP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Helmerich & Payne, Inc. (NYSE: HP) CFO has 2,150 shares withheld

Helmerich & Payne, Inc. CFO Todd N. Scruggs reported a non-market disposition of 2,150 common shares, which were withheld at $34.57 per share to cover an exercise price or tax liability. Following this transaction, Scruggs directly holds 39,981 common shares. This insider transaction was …

HP main company
Sharemaestro market context Trend signal started 52 weeks +139.0% HP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

The Elmet Group Co. Schedules Second Quarter 2026 Earnings Call

The Elmet Group Co. (ELMT) announced its second quarter 2026 earnings call, scheduled for Thursday, August 13, 2026, at 9:00 a.m. Eastern Time. Management will discuss financial results for the quarter ending June 30, 2026, followed by a Q&A session. A press release with …

ELMT main company
Sharemaestro market context Stored weekly price path 17 weeks +10.7% · Next-week setup negative 33.5% ELMT stored weekly price path from 24 Apr 2026 to 14 Aug 2026

Elmet Group Sets Aug. 13 Call to Discuss Second-Quarter Results

The Elmet Group (NASDAQ: ELMT) has scheduled a conference call and webcast for August 13, 2026, at 9:00 a.m. Eastern Time, to discuss its second-quarter 2026 financial results. A detailed earnings press release will precede the call, which will include a Q&A session with …

ELMT main company
Sharemaestro market context Stored weekly price path 17 weeks +10.7% · Next-week setup negative 33.5% ELMT stored weekly price path from 24 Apr 2026 to 14 Aug 2026

ETFs Investing in Elme Communities Stocks

This article lists several ETFs that invest in Elme Communities (ELME) stocks, providing details such as market value, weight, issuer, management style, expense ratio, and AUM for each fund. It aims to help investors find accessible and lower-risk opportunities to invest in ELME through …

ELME main company
Sharemaestro market context Price below Trend Line 52 weeks -39.2% ELME stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Elme Communities 3Q 2025: Revenue $62.1M, EPS $(0.04) — 10-Q Summary

Elme Communities reported its third-quarter 2025 financial results, showing real estate rental revenue of $62.1 million and a net loss of $3.57 million, leading to a diluted EPS of $(0.04). The company is currently undergoing a plan of sale and liquidation, having sold six …

ELME main company
Sharemaestro market context Price below Trend Line 52 weeks -39.2% ELME stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Relmada Therapeutics Appoints Bipin Dalmia as Chief Business Officer to Advance NDV-01 and Corporate Growth

Relmada Therapeutics has announced the appointment of Bipin Dalmia as its new Chief Business Officer. In this role, Dalmia will be responsible for leading business development strategies to advance the company's lead asset, NDV-01, and drive overall corporate growth. His appointment is expected to …

RLMD main company
Sharemaestro market context Price below Trend Line 52 weeks +665.6% RLMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Janus Henderson Group PLC Increases Position in Relmada Therapeutics, Inc. $RLMD

Janus Henderson Group PLC significantly increased its stake in Relmada Therapeutics (NASDAQ:RLMD) by 52.2% in the first quarter, now owning over 11 million shares, representing 10.55% of the company. Institutional investors collectively hold 45.24% of RLMD, and analysts have a "Moderate Buy" rating with …

RLMD main company
Sharemaestro market context Price below Trend Line 52 weeks +665.6% RLMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Elme Communities Revenue Breakdown – NYSE:ELME

The article provides a brief financial overview for Elme Communities (NYSE: ELME) on TradingView, listing its stock exchange information and indicating that market data is provided by ICE Data Services and FactSet. It primarily focuses on navigating the financial data available for ELME on …

ELME main company
Sharemaestro market context Price below Trend Line 52 weeks -39.2% ELME stored weekly price path from 22 Aug 2025 to 14 Aug 2026

GEG|Great Elm Group Inc|Price:2.150|Chg%:-0.050

Great Elm Group Inc (GEG) has a current stock price of $2.240, experiencing a 4.19% increase. The company's fundamentals are considered healthy with good growth potential, though its valuation is seen as fairly valued within its industry. Analysts currently rate GEG as a "Hold," …

GEG main company
Sharemaestro market context Trend signal active 52 weeks -12.6% · Next-week setup negative 42.1% GEG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Elme Communities (NYSE: ELME) advances liquidation, targets late‑2026 wind‑down

Elme Communities (NYSE: ELME) is progressing with its shareholder-approved Plan of Sale and Liquidation, reporting net assets of $167.7 million as of June 30, 2026. The company has sold several properties, paid a special liquidating distribution of $14.67 per share in January 2026, and …

ELME main company
Sharemaestro market context Price below Trend Line 52 weeks -39.2% ELME stored weekly price path from 22 Aug 2025 to 14 Aug 2026

4 Energy Stocks That Could Surpass Q2 Earnings Estimates

The article identifies four energy stocks—Calumet (CLMT), Western Midstream Partners (WES), Helmerich & Payne (HP), and Transocean Ltd. (RIG)—that are poised to exceed Q2 earnings estimates. This positive forecast is attributed to a strong commodity-price environment, disciplined spending, and improved operating conditions in the …

HP main company
Sharemaestro market context Trend signal started 52 weeks +139.0% HP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Great Elm Capital Corp (GECC) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Great Elm Capital Corp (GECC), stating its current valuation score is 7.65, placing it 13th out of 25 in the Collective Investments industry. It notes GECC's current P/E ratio is -1.93, significantly below its recent high and …

GECC main company
Sharemaestro market context Trend signal started 52 weeks -36.4% · Next-week setup positive 55.4% GECC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Helmerich & Payne (HP) Expected to Beat Earnings Estimates: Should You Buy?

Helmerich & Payne (HP) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results …

HP main company
Sharemaestro market context Trend signal started 52 weeks +139.0% HP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Great Elm Group Inc (GEG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Great Elm Group Inc (GEG) by business segment, including Equipment Sales, Medical Equipment Rental Income, and Service Revenues. The data, updated as of March 3, 2025, shows that Equipment Sales constitute the largest proportion of revenue. …

GEG main company
Sharemaestro market context Trend signal active 52 weeks -12.6% · Next-week setup negative 42.1% GEG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Relmada Therapeutics Inc (RLMD) Financial Health: Profitability & Balance Sheet Analysis

Relmada Therapeutics Inc (RLMD) currently holds a financial score of 5.49, placing it low within the Biotechnology & Medical Research industry, reflecting weak financial status and low operating efficiency. The report indicates that the company has not yet disclosed relevant data for several key …

RLMD main company
Sharemaestro market context Price below Trend Line 52 weeks +665.6% RLMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Helmerich & Payne Number of Employees 2026 | Employee Count & Headcount Data

Helmerich & Payne (HP) had approximately 15,903 employees worldwide as of March 2026, representing a 1.9% decline from 2023. The company is actively hiring, with 99 active job postings in 2026, a 44.4% increase from 2025. The workforce is concentrated in the United States, …

HP main company
Sharemaestro market context Trend signal started 52 weeks +139.0% HP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Helmerich & Payne (HP) Expected to Announce Earnings on Wednesday

Helmerich & Payne (HP) is scheduled to report its Q3 2026 earnings after market close on Wednesday, August 5th, with analysts projecting earnings of $0.11 per share and revenue of $987.7 million. This follows a previous quarter where the company missed expectations, reporting a …

HP main company
Sharemaestro market context Trend signal started 52 weeks +139.0% HP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Helmerich & Payne (HP): Buy, Sell, or Hold Post Q1 Earnings?

Helmerich & Payne (HP) has shown significant revenue growth and an improved EBITDA margin, indicating strong operational leverage. However, its low gross margin suggests potential struggles in lower commodity price environments. Despite the mixed signals, the article concludes that the company's merits outweigh its …

HP main company
Sharemaestro market context Trend signal started 52 weeks +139.0% HP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

With New $250M Deal, Elme Is Fully Set To Liquidate

Elme Communities has secured a new $250 million deal to sell its Riverside Apartments, a 1,222-unit complex in Alexandria, Virginia, to FPA Multifamily LLC. This new agreement comes after a previous $280 million deal fell through, allowing Elme to get back on track with …

ELME main company
Sharemaestro market context Price below Trend Line 52 weeks -39.2% ELME stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Relmada names Bipin Dalmia as chief business officer By Investing.com

Relmada Therapeutics, Inc. has appointed Bipin Dalmia as its new Chief Business Officer. Dalmia brings nearly 30 years of biopharmaceutical experience, having previously led portfolio strategy and business development at Ferring Pharmaceuticals, where he also played a key role in the U.S. launch of …

RLMD main company
Sharemaestro market context Price below Trend Line 52 weeks +665.6% RLMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Relmada names Bipin Dalmia as Chief Business Officer to advance NDV-01 and commercial strategy

Relmada Therapeutics has appointed Bipin Dalmia as its new Chief Business Officer, reporting directly to CEO Sergio Traversa. Dalmia will be responsible for leading corporate strategy, commercial planning, and business development, specifically focusing on the late-stage development of NDV-01. This appointment highlights Relmada's commitment …

RLMD main company
Sharemaestro market context Price below Trend Line 52 weeks +665.6% RLMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Relmada names Bipin Dalmia as chief business officer

Relmada Therapeutics, Inc. has appointed Bipin Dalmia as its new Chief Business Officer. Dalmia, who brings nearly 30 years of biopharmaceutical experience, will be responsible for leading the company’s corporate strategy, commercial planning, and business development initiatives. He previously served at Ferring Pharmaceuticals, where …

RLMD main company
Sharemaestro market context Price below Trend Line 52 weeks +665.6% RLMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Relmada hires executive with U.S. bladder cancer gene therapy experience

Relmada Therapeutics (Nasdaq: RLMD) has appointed Bipin Dalmia, PhD, MBA, as its Chief Business Officer. Dalmia brings nearly 30 years of biopharmaceutical leadership, including experience leading the Uro-Oncology Franchise and the U.S. launch of ADSTILADRIN, the first FDA-approved intravesical gene therapy for BCG-unresponsive non-muscle …

RLMD main company
Sharemaestro market context Price below Trend Line 52 weeks +665.6% RLMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context